Global Meniere’s Disease Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 156297
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

Ménière's disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like the world is spinning (vertigo), ringing in the ears (tinnitus), hearing loss, and a fullness in the ear. Typically only one ear is affected, at least initially; however, over time both ears may become involved. Episodes generally last from 20 minutes to a few hours. The time between episodes varies. The hearing loss and ringing in the ears may become constant over time.

Scope of the Report:

This report studies the Meniere’s Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Meniere’s Disease market by product type and applications/end industries.

There is no cure for Ménière's disease but medications, diet, physical therapy and counseling, and some surgical approaches can be used to manage it.

The global Meniere’s Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Meniere’s Disease.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Auris Medical

Jubilant Cadista

Otonomy

Prestige Brands Holdings

Sound Pharmaceuticals

The Ear Company

WellSpring Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hearing Assessment

Balance Assessment

Blood Tests

Imaging Test

Others

Market Segment by Applications, can be divided into

Hospital And Clinics

Medical Research Centers

Academic Institutes

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Meniere’s Disease Market Overview

1.1 Product Overview and Scope of Meniere’s Disease

1.2 Classification of Meniere’s Disease by Types

1.2.1 Global Meniere’s Disease Revenue Comparison by Types (2017-2023)

1.2.2 Global Meniere’s Disease Revenue Market Share by Types in 2017

1.2.3 Hearing Assessment

1.2.4 Balance Assessment

1.2.5 Blood Tests

1.2.6 Imaging Test

1.2.7 Others

1.3 Global Meniere’s Disease Market by Application

1.3.1 Global Meniere’s Disease Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital And Clinics

1.3.3 Medical Research Centers

1.3.4 Academic Institutes

1.3.5 Others

1.4 Global Meniere’s Disease Market by Regions

1.4.1 Global Meniere’s Disease Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Meniere’s Disease Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Meniere’s Disease Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Meniere’s Disease Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Meniere’s Disease Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Meniere’s Disease Status and Prospect (2013-2023)

1.5 Global Market Size of Meniere’s Disease (2013-2023)

2 Manufacturers Profiles

2.1 Auris Medical

2.1.1 Business Overview

2.1.2 Meniere’s Disease Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Auris Medical Meniere’s Disease Revenue, Gross Margin and Market Share (2016-2017)

2.2 Jubilant Cadista

2.2.1 Business Overview

2.2.2 Meniere’s Disease Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Jubilant Cadista Meniere’s Disease Revenue, Gross Margin and Market Share (2016-2017)

2.3 Otonomy

2.3.1 Business Overview

2.3.2 Meniere’s Disease Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Otonomy Meniere’s Disease Revenue, Gross Margin and Market Share (2016-2017)

2.4 Prestige Brands Holdings

2.4.1 Business Overview

2.4.2 Meniere’s Disease Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Prestige Brands Holdings Meniere’s Disease Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sound Pharmaceuticals

2.5.1 Business Overview

2.5.2 Meniere’s Disease Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sound Pharmaceuticals Meniere’s Disease Revenue, Gross Margin and Market Share (2016-2017)

2.6 The Ear Company

2.6.1 Business Overview

2.6.2 Meniere’s Disease Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 The Ear Company Meniere’s Disease Revenue, Gross Margin and Market Share (2016-2017)

2.7 WellSpring Pharmaceutical

2.7.1 Business Overview

2.7.2 Meniere’s Disease Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 WellSpring Pharmaceutical Meniere’s Disease Revenue, Gross Margin and Market Share (2016-2017)

3 Global Meniere’s Disease Market Competition, by Players

3.1 Global Meniere’s Disease Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Meniere’s Disease Players Market Share

3.2.2 Top 10 Meniere’s Disease Players Market Share

3.3 Market Competition Trend

4 Global Meniere’s Disease Market Size by Regions

4.1 Global Meniere’s Disease Revenue and Market Share by Regions

4.2 North America Meniere’s Disease Revenue and Growth Rate (2013-2018)

4.3 Europe Meniere’s Disease Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Meniere’s Disease Revenue and Growth Rate (2013-2018)

4.5 South America Meniere’s Disease Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Meniere’s Disease Revenue and Growth Rate (2013-2018)

5 North America Meniere’s Disease Revenue by Countries

5.1 North America Meniere’s Disease Revenue by Countries (2013-2018)

5.2 USA Meniere’s Disease Revenue and Growth Rate (2013-2018)

5.3 Canada Meniere’s Disease Revenue and Growth Rate (2013-2018)

5.4 Mexico Meniere’s Disease Revenue and Growth Rate (2013-2018)

6 Europe Meniere’s Disease Revenue by Countries

6.1 Europe Meniere’s Disease Revenue by Countries (2013-2018)

6.2 Germany Meniere’s Disease Revenue and Growth Rate (2013-2018)

6.3 UK Meniere’s Disease Revenue and Growth Rate (2013-2018)

6.4 France Meniere’s Disease Revenue and Growth Rate (2013-2018)

6.5 Russia Meniere’s Disease Revenue and Growth Rate (2013-2018)

6.6 Italy Meniere’s Disease Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Meniere’s Disease Revenue by Countries

7.1 Asia-Pacific Meniere’s Disease Revenue by Countries (2013-2018)

7.2 China Meniere’s Disease Revenue and Growth Rate (2013-2018)

7.3 Japan Meniere’s Disease Revenue and Growth Rate (2013-2018)

7.4 Korea Meniere’s Disease Revenue and Growth Rate (2013-2018)

7.5 India Meniere’s Disease Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Meniere’s Disease Revenue and Growth Rate (2013-2018)

8 South America Meniere’s Disease Revenue by Countries

8.1 South America Meniere’s Disease Revenue by Countries (2013-2018)

8.2 Brazil Meniere’s Disease Revenue and Growth Rate (2013-2018)

8.3 Argentina Meniere’s Disease Revenue and Growth Rate (2013-2018)

8.4 Colombia Meniere’s Disease Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Meniere’s Disease by Countries

9.1 Middle East and Africa Meniere’s Disease Revenue by Countries (2013-2018)

9.2 Saudi Arabia Meniere’s Disease Revenue and Growth Rate (2013-2018)

9.3 UAE Meniere’s Disease Revenue and Growth Rate (2013-2018)

9.4 Egypt Meniere’s Disease Revenue and Growth Rate (2013-2018)

9.5 Nigeria Meniere’s Disease Revenue and Growth Rate (2013-2018)

9.6 South Africa Meniere’s Disease Revenue and Growth Rate (2013-2018)

10 Global Meniere’s Disease Market Segment by Type

10.1 Global Meniere’s Disease Revenue and Market Share by Type (2013-2018)

10.2 Global Meniere’s Disease Market Forecast by Type (2018-2023)

10.3 Hearing Assessment Revenue Growth Rate (2013-2023)

10.4 Balance Assessment Revenue Growth Rate (2013-2023)

10.5 Blood Tests Revenue Growth Rate (2013-2023)

10.6 Imaging Test Revenue Growth Rate (2013-2023)

10.7 Others Revenue Growth Rate (2013-2023)

11 Global Meniere’s Disease Market Segment by Application

11.1 Global Meniere’s Disease Revenue Market Share by Application (2013-2018)

11.2 Meniere’s Disease Market Forecast by Application (2018-2023)

11.3 Hospital And Clinics Revenue Growth (2013-2018)

11.4 Medical Research Centers Revenue Growth (2013-2018)

11.5 Academic Institutes Revenue Growth (2013-2018)

11.6 Others Revenue Growth (2013-2018)

12 Global Meniere’s Disease Market Size Forecast (2018-2023)

12.1 Global Meniere’s Disease Market Size Forecast (2018-2023)

12.2 Global Meniere’s Disease Market Forecast by Regions (2018-2023)

12.3 North America Meniere’s Disease Revenue Market Forecast (2018-2023)

12.4 Europe Meniere’s Disease Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Meniere’s Disease Revenue Market Forecast (2018-2023)

12.6 South America Meniere’s Disease Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Meniere’s Disease Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Meniere’s Disease Picture

Table Product Specifications of Meniere’s Disease

Table Global Meniere’s Disease and Revenue (Million USD) Market Split by Product Ty

Please fill the form below, to recieve the report sample


+1